Open Access

Essentials of cardiac disease prevention for cancer patients

Event: ESC Preventive Cardiology 2022
Topic: Cardio-Oncology
Session type: Special Session
Date: 7 April 2022
Time: 10:15 - 11:00

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

11 presentations in this session

How exactly does chemotherapy damage the heart?

Speaker: Doctor Z. Iakobishvili (Tel Aviv, IL)
Thumbnail

Discussion - How exactly does chemotherapy damage the heart?

Thumbnail

How to prevent cardiotoxicity of cancer treatments: can exercise help?

Speaker: Doctor M. Mirabel (Paris, FR)
Thumbnail

Discussion - How to prevent cardiotoxicity of cancer treatments: can exercise help?

Thumbnail

How to identify long-term cardiotoxicity: from biomarkers to imaging

Speaker: Doctor T. Lopez Fernandez (Madrid, ES)
Thumbnail

Discussion - How to identify long-term cardiotoxicity: from biomarkers to imaging

Thumbnail

Cardio-oncology training for physicians: improving cardiac prevention in cancer

Speaker: Professor T. Suter (Bern, CH)
Thumbnail

Discussion - Cardio-oncology training for physicians: improving cardiac prevention in cancer

Thumbnail

How to set up a cardio-oncology unit

Speaker: Doctor R. Asteggiano (Turin, IT)
Thumbnail

Discussion - How to set up a cardio-oncology unit

Thumbnail

5 speakers from this session

Doctor Zaza Iakobishvili

Holon Medical Center, Tel Aviv (Israel)
3 presentations
0 follower

Doctor Mariana Mirabel

Montsouris Mutualist Institute, Paris (France)
3 presentations
0 follower

Doctor Teresa Lopez Fernandez

University Hospital La Paz, Madrid (Spain)
17 presentations
0 follower

Professor Thomas Suter

University Hospital, Bern (Switzerland)
14 presentations
1 follower

Doctor Riccardo Asteggiano

LARC (Laboratorio Analisi Ricerca Clinica, Turin (Italy)
7 presentations
0 follower

Related content

Open Access

Pregnancy in women with cardiovascular disease

3 December 2021

Open Access

Current controversies in antithrombotic therapy

3 December 2021

Open Access

Opening session

2 December 2021

This platform is supported by

logo Novo Nordisk